Formulations for Ussing chamber flux and in vivo 59Fe absorption studies*
Compound . | Concentration (mM) . | AA† . | Concentration (mM) . |
---|---|---|---|
NaCl | 103 (86)‡ | Aspartic acid | 8 |
KCl | 5.2 | Glutamine | 8 |
NaH2PO4 | 7.6 | Glycine | 8 |
Na2HPO4 | 1.4 | Glutamic acid§ | 6.3 |
MgCl2 | 1.2 | ||
CaCl2· 2H2O | 1.2 | ||
Na citrate monobasic | 25 | ||
FeSO4 · 7 H2O | 1.5ǁ |
Compound . | Concentration (mM) . | AA† . | Concentration (mM) . |
---|---|---|---|
NaCl | 103 (86)‡ | Aspartic acid | 8 |
KCl | 5.2 | Glutamine | 8 |
NaH2PO4 | 7.6 | Glycine | 8 |
Na2HPO4 | 1.4 | Glutamic acid§ | 6.3 |
MgCl2 | 1.2 | ||
CaCl2· 2H2O | 1.2 | ||
Na citrate monobasic | 25 | ||
FeSO4 · 7 H2O | 1.5ǁ |